Literature DB >> 9557178

[Bronchial carcinoid tumors: a prospective study].

E Pareja1, A Arnau, E Artigues, F Peiró, F Hostalet, E Martín, A Cantó.   

Abstract

We report the results of a study performed in the thoracic surgery department of Hospital General Universitario of Valencia from October 1989 to December 1996. Of the 621 patients diagnosed of lung cancer during this period, 320 underwent the usual surgical excision, 18 were confirmed histologically as bronchial carcinoid tumors, indicating an incidence of 5.6% of all pulmonary neoplasms resected in our department. The symptoms most often reported were recurring infection (44.5%) and chest pain (33.3%). Only one patient presented carcinoid syndrome. The most common radiologic presentation was solitary pulmonary nodule (50%). The tumor was visible by fiberoptic bronchoscopy in 9 cases. Diagnosis was by bronchial biopsy in four cases. Confirmation was by immunohistochemical analysis of the specimen in all cases. Electron microscopy and immunohistochemical techniques using neuroendocrine panmarkers is considered fundamental for differentiating between neuroendocrine neoplasms and typical and atypical carcinoid tumors. Thirteen (72.2%) of the 18 patients studied were diagnosed of typical carcinoids and 5 (27.8%) of atypical carcinoids. Neuroendocrine marking showed neurospecific enolase in 15 patients and chromogranin positivity in 10.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557178     DOI: 10.1016/s0300-2896(15)30484-1

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  2 in total

1.  Local recurrence and metastatic disease in a typical N1 carcinoid bronchial tumour.

Authors:  Miguel Angel Cañizares; Eva M García-Fontán; José Eduardo Rivo; Ana Gonzalez-Piñeiro
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

2.  Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.

Authors:  Martijn van Essen; Eric P Krenning; Willem H Bakker; Wouter W de Herder; Maarten O van Aken; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-27       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.